Literature DB >> 2432061

Transcription initiation by RNA polymerase II in vitro. Properties of preinitiation, initiation, and elongation complexes.

H Cai, D S Luse.   

Abstract

We have prepared three types of RNA polymerase II transcription complexes: a preinitiation complex (complex 0), a complex which has synthesized two phosphodiester bonds (complex 2), and a complex which has synthesized 10-13 bonds (complex 10). We have studied the differential response of these complexes to a variety of disruptions: detergent (Sarkosyl), high levels of KCl, extended incubation at 25 degrees C, proteolysis, and digestion with DNase I. Complex 0 is extremely stable at 25 degrees C in the absence of ATP, but it is sensitive to the other treatments including 25 degrees C incubation in the presence of ATP. Once the complex has made two phosphodiester bonds, the properties almost reverse from those of complex 0; complex 2 remains unstable at 25 degrees C in the presence of ATP but is resistant to high levels of Sarkosyl and KCl, to extensive DNase I digestion, and to brief proteolysis. Addition of 10 or more bases to the growing RNA chain results in a complex completely resistant to all of the treatments used. When DNase I-trimmed complex 0 is allowed to initiate RNA synthesis, chains of about 33 bases are obtained. In contrast, DNase-trimmed complex 2 gives only about 23 base transcripts; DNase-treated complex 10 will elongate its nascent chains by about 21 bases as well (to give, on average, 34 base transcripts).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2432061

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Discrete promoter elements affect specific properties of RNA polymerase II transcription complexes.

Authors:  J W Steinke; S J Kopytek; D O Peterson
Journal:  Nucleic Acids Res       Date:  2000-07-15       Impact factor: 16.971

2.  Translocation after synthesis of a four-nucleotide RNA commits RNA polymerase II to promoter escape.

Authors:  Jennifer F Kugel; James A Goodrich
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

3.  In vitro analysis of a transcription termination site for RNA polymerase II.

Authors:  D K Wiest; D K Hawley
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

4.  An 8 nt RNA triggers a rate-limiting shift of RNA polymerase II complexes into elongation.

Authors:  Aaron R Hieb; Sean Baran; James A Goodrich; Jennifer F Kugel
Journal:  EMBO J       Date:  2006-06-15       Impact factor: 11.598

5.  RNA polymerase II elongation complexes paused after the synthesis of 15- or 35-base transcripts have different structures.

Authors:  S C Linn; D S Luse
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

6.  Footprinting analysis of mammalian RNA polymerase II along its transcript: an alternative view of transcription elongation.

Authors:  G A Rice; C M Kane; M J Chamberlin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

7.  Postrecruitment regulation of RNA polymerase II directs rapid signaling responses at the promoters of estrogen target genes.

Authors:  Miltiadis Kininis; Gary D Isaacs; Leighton J Core; Nasun Hah; W Lee Kraus
Journal:  Mol Cell Biol       Date:  2008-12-22       Impact factor: 4.272

8.  RNA polymerase II-associated proteins are required for a DNA conformation change in the transcription initiation complex.

Authors:  S Buratowski; M Sopta; J Greenblatt; P A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

9.  Regulation of the p53 transcriptional response by structurally diverse core promoters.

Authors:  José M Morachis; Christopher M Murawsky; Beverly M Emerson
Journal:  Genes Dev       Date:  2009-12-29       Impact factor: 11.361

10.  Native elongating transcript sequencing reveals human transcriptional activity at nucleotide resolution.

Authors:  Andreas Mayer; Julia di Iulio; Seth Maleri; Umut Eser; Jeff Vierstra; Alex Reynolds; Richard Sandstrom; John A Stamatoyannopoulos; L Stirling Churchman
Journal:  Cell       Date:  2015-04-23       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.